The Priority Review

Clinical trials Brief

Gilead posts results of Phase 3 ARTISTRY-2 study of BIC/LEN versus B/F/TAF

Results for the Phase 3 ARTISTRY-2 study were first posted on ClinicalTrials.gov on November 5, 2026. The study enrolled 577 participants and completed primary data collection on October 27, 2025.

Primary source

ClinicalTrials.gov results record, November 5, 2026

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

Read the source: Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy clinicaltrials.gov

Machine-summarized from the source above; not independently reported. How we use automation